DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $144 | +278.9% | 6,293 | +355.4% | 0.00% | – |
Q4 2022 | $38 | -100.0% | 1,382 | -59.9% | 0.00% | – |
Q3 2022 | $105,000 | -74.9% | 3,450 | -63.2% | 0.00% | – |
Q4 2021 | $418,000 | +1572.0% | 9,376 | +1988.2% | 0.00% | – |
Q1 2021 | $25,000 | – | 449 | +454.3% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 81 | -96.9% | 0.00% | – |
Q1 2020 | $45,000 | -63.4% | 2,603 | -63.4% | 0.00% | – |
Q4 2019 | $123,000 | +3.4% | 7,115 | -9.0% | 0.00% | – |
Q3 2019 | $119,000 | +5850.0% | 7,815 | +6412.5% | 0.00% | – |
Q2 2019 | $2,000 | -83.3% | 120 | -77.9% | 0.00% | – |
Q1 2019 | $12,000 | -50.0% | 543 | -51.3% | 0.00% | – |
Q3 2018 | $24,000 | – | 1,114 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 19,462,500 | $298,165,000 | 48.02% |
Bratton Capital Management, L.P. | 953,035 | $14,600,000 | 28.53% |
Flagship Pioneering Inc. | 8,005,747 | $122,648,000 | 6.71% |
Casdin Capital, LLC | 650,000 | $9,958,000,000 | 1.03% |
Temasek Holdings (Private) Ltd | 4,410,457 | $67,568,000 | 0.50% |
MARK ASSET MANAGEMENT LP | 68,864 | $1,055,000 | 0.26% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 22,507 | $345,000 | 0.26% |
Artal Group S.A. | 400,000 | $6,128,000 | 0.25% |
PIER 88 INVESTMENT PARTNERS LLC | 40,610 | $622,000 | 0.24% |
HAMILTON LANE ADVISORS LLC | 30,948 | $474,000 | 0.20% |